Bone Marrow with Diffuse Tumor Infiltration in Patients with Lymphoproliferative Diseases: Dynamic Gadolinium-enhanced MR Imaging

Radiology

Volumn 229, Issue 3, 2003, Pages 710-717

  Rahmouni, Alain ^a   Montazel, Jean Luc ^a   Divine, Marine ^a   Lepage, Eric ^a   Belhadj, Karim ^a   Gaulard, Philippe ^a   Bouanane, Mohamed ^a   Golli, Mondher ^a   Kobeiter, Hicham ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Bone marrow; Contrast enhancement; Gadolinium Hodgkin disease; Lymphoma; Magnetic resonance (MR); MR; Myeloma; Neoplasms

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; BLEOMYCIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; GADOLINIUM; GADOTERATE MEGLUMINE; GADOTERIC ACID; MELPHALAN; PREDNISONE; PROCARBAZINE; STEROID; VINBLASTINE; VINCRISTINE; VINDESINE;

ADULT; AGED; ARTICLE; BONE MARROW TUMOR; CANCER INVASION; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; HISTOLOGY; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LYMPHOPROLIFERATIVE DISEASE; MALE; MYELOMA; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; THORACOLUMBAR SPINE; TUMOR CELL;

ADULT; AGED; BONE MARROW; FOLLOW-UP STUDIES; GADOLINIUM; HODGKIN DISEASE; HUMANS; LYMPHOMA, NON-HODGKIN; LYMPHOPROLIFERATIVE DISORDERS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; ROC CURVE; SENSITIVITY AND SPECIFICITY; SPINE;

EID: 0345446717     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2293020748     Document Type: Article

References (30)

1. Hoane BR, Shields AF, Porter BA, Shulman HM. Detection of lymphomatous bone marrow involvement with magnetic resonance imaging. Blood 1991; 78:728-738.
2. Rahmouni A, Divine M, Mathieu D, et al. Detection of multiple myeloma involving the spine: efficacy of fat-suppression and contrast-enhanced MR imaging. AJR Am J Roentgenol 1993; 160:1049-1052.
3. Stäbler A, Baur A, Bartl R, Munker R, Lamerz R, Reiser MF. Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival rates. AJR Am J Roentgenol 1996; 167:1029-1036.
4. Moulopoulos LA, Varma DGK, Dimopoulos MA, et al. Multiple myeloma: spinal MR imaging in patients with untreated newly diagnosed disease. Radiology 1992; 185:833-840.
5. Vande Berg BC, Lecouvet FE, Michaux L, Ferrant A, Maldague B, Malghem J. Magnetic resonance imaging of the bone marrow in hematological malignancies. Eur Radiol 1998; 87:1335-1344.
6. Ricci C, Cova M, Kang YS, et al. Normal age-related patterns of cellular and fatty bone marrow distribution in the axial skeleton: MR imaging study. Radiology 1990; 177:83-88.
7. Vande Berg BC, Malghem J, Lecouvet FE, Maldague B. Magnetic resonance imaging of normal bone marrow. Eur Radiol 1998; 8:1327-1334.
8. Vande Berg BC, Lecouvet FE, Michaux L, et al. Stage I multiple myeloma: value of MR imaging of the bone marrow in the determination of prognosis. Radiology 1996; 201:243-246.
9. Lecouvet FE, Vande Berg BC, Michaux L, et al. Stage III multiple myeloma: clinical and prognostic value of spinal bone marrow MR imaging. Radiology 1998; 209: 653-660.
10. Ishijima H, Ishikaza H, Horikoshi H, Sakurai M. Water fraction of lumbar vertebral bone marrow estimated from chemical shift misregistration on MR imaging: normal variations with age and sex. AJR Am J Roentgenol 1995; 167:355-358.
11. Gerard EL, Ferry JA, Amrein PC, et al. Compositional changes in vertebral bone marrow during treatment for acute leukemia: assessment with quantitative chemical shift imaging. Radiology 1992; 183: 39-46.
12. Vande Berg BC, Schmitz PJ, Scheiff JM, et al. Acute myeloid leukemia: lack of predictive value of sequential quantitative MR imaging during treatment. Radiology 1995; 197:301-305.
13. Schick F, Einsele H, Lutz O, Claussen CD. Lipid selective MR imaging and localized 1H spectroscopy of bone marrow during therapy of leukemia. Anticancer Res 1996; 16:1545-1551.
14. Vacca A, Ribatti D, Roncali L, Dammacco F. Angiogenesis in B cell lymphoproliferative diseases: biological and clinical studies. Leuk Lymphoma 1995; 20:27-38.
15. Vacca A, Ribatti D, Presta M, et al. Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood 1999; 93:3064-3073.
16. Ribatti D, Vacca A, Nico B, Fanelli M, Roncali L, Dammacco F. Angiogenesis spectrum in the stroma of B-cell non-Hodgkin's lymphomas: an immunohistochemical and ultrastructural study. Eur J Haematol 1996; 56:45-53.
17. Taylor JS, Tofts PS, Phil D, et al. MR imaging of tumor microcirculation: promise for the new millennium. J Magn Reson Imaging 1999; 10:903-907.
18. Dao T, Rahmouni A, Campana F, Laurent M, Asselain B, Fourquet A. Tumor recurrence versus fibrosis in the irradiated breast: differentiation with dynamic gadolinium-enhanced MR imaging. Radiology 1993; 187:751-755.
19. De Baere T, Vanel D, Shapeero LG, Charpentier A, Terrier P, Di Paola M. Osteosarcoma after chemotherapy: evaluation with contrast material-enhanced subtraction MR imaging. Radiology 1992; 185: 587-592.
20. Verstraete KL, De Deene Y, Roels H, Dierick A, Uyttendaele D, Kunnen M. Benign and malignant musculoskeletal lesions: dynamic contrast-enhanced MR imaging-parametric "first-pass" images depict tissue vascularization and perfusion. Radiology 1994; 192:835-843.
21. Salmon SE, Cassady JR. Plasma cell neoplasms. In: De Vita VT, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology. 4th ed. Philadelphia, Pa: Lippincott, 1995; 1984-2025.
22. Montazel JL, Divine M, Lepage E, Kobeiter H, Breil S, Rahmouni A. Normal spinal bone marrow in adults: dynamic gadolinium-enhanced MR imaging. Radiology 2003; 229:000-000.
23. Chronic Leukemia-Myeloma Task Force. Proposed guidelines for protocol studies: plasma cell myeloma. Cancer Treat Rep 1973; 4:145-158.
24. Parker GJM, Suckling J, Tanner SF, et al. MRIW: parametric analysis software for contrast-enhanced dynamic MR imaging in cancer. RadioGraphics 1998; 18:497-506.
25. Vacca A, Di Loreto M, Ribatti D, et al. Bone marrow of patients with active multiple myeloma: angiogenesis and plasma cell adhesion molecules LFA-1, VLA-4, LAM-1, and CD44. Am J Hematol 1995; 50:9-14.
26. Rahmouni A, Divine M, Mathieu D, et al. MR appearance of multiple myeloma of the spine before and after treatment. AJR Am J Roentgenol 1993; 160:1053-1057.
27. Moehler TM, Hawighorst H, Neben K, et al. Bone marrow microcirculation analysis in multiple myeloma by contrast-enhanced dynamic magnetic resonance imaging. Int J Cancer 2001; 93:862-868.
28. Moulopoulos LA, Dimopoulos MA, Alexanian R, et al. Multiple myeloma: MR patterns of response of treatment. Radiology 1994; 193:441-446.
29. Singhal S, Mehta J, Desikan R, et al. Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med 1999; 341:1565-1571.
30. Baur A, Stäbler A, Bartl R, Lamerz R, Scheidler J, Reiser M. MRI gadolinium enhancement of bone marrow: age-related changes in normals and in diffuse neoplastic infiltration. Skeletal Radiol 1997; 26:414-418.